Leadership Team 2018-2019

President

Bo Ying, Ph.D. Director, Formulation & Drug Product Development, Truecode Gene Repair Inc.

Chairman of the Board

Philip Zhang, Ph. D., J. D. Past President (2012-2013), Co-Founder and Chairman, Milstein Zhang & Wu LLC, Newton, MA

President-Elect

Lan Cao, Ph.D. Executive Director, TechOps, Technical Leader, CRISPR Therapeutics, Cambridge, MA

Vice President 

Jian Shao, MBA, Senior Director, Simcere Pharmaceutical Group

Wendy Yang, MBA, Manager, R&D Operational Planning and Capacity Management - CMC, Sanofi US, Waltham, MA

Ben Wei, Ph.D. MBA, Director, BD APAC, PerkinElmer

Vice President of Finance

Zhendong Zhu, Ph.D. Principal Investigator, Celgene Avilomics Research, Bedford, MA

General Manager of Public Relations

Qingqing Cao, Ph.D. & MBA Head of Portfolio & Program Management (Director), Quanterix, Billerica, MA

General Manager of Operations

Ellen Fan, MSc., Ph.D. Candidate, Senior Scientist, Smith & Nephew, Andover, MA

Director of Scientific Programs

Lan Cao, Ph.D. Executive Director, TechOps, Technical Leader, CRISPR Therapeutics, Cambridge, MA

Director of Communication

Shujia Daniel Dai, Ph.D. Principal Research Investigator, Sanofi-Aventis

Treasurer

Liping Zhou, Ph.D. Senior Scientist, Ipsen Biosciences., Cambridge, MA

Legal Counsel

Fred Gilman, Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA

 

Executive Committee Members

Hao Cai, BD Manager, Huacells

Qinglin Che, Ph.D. Senior Scientist, Tetraphase Pharmaceuticals, Inc., Watertown, MA

Yin Chen, Ph.D. Director of Business Development at Accelagen

Ruiyi Dong, Associate Scientist Ⅱ, Biogen

Kevin Fang, Ph.D. Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA

Henry Gu, J.D. Intellectual Property Counsel, Agios Pharmaceuticals, Cambridge, MA

Jianfeng Jeff Hang, Ph.D. Principal Qualify Engineer, Exosome Diagnostics, Inc., Waltham, MA

Jing Huang, Ph.D., Researcher, Boston Children’s Hospital and Harvard Medical School 

Pengyu Huang, Staff Scientist, Acetylon Pharmaceuticals, Inc

Jo Lee, M.Ec. Founder, Somebusiness, Inc.

Hao Howard Li, Ph.D. MBA, President, COO, Sanova Bioscience, Inc., Acton, MA

Jing Jeannie Li, Ph.D. Senior Scientist, Pfizer, Cambridge, MA

Dandan Ling, Senior Research Associate, Intellia Therapeutics, Inc

Carrie Liu, Ph.D. Associate Director of Technical Operation, Analytical, Vertex Pharmaceuticals, Boston, MA

Sue Ma, M.D. Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA

Jianyu Shang, Research Associate  II, Voyager Therapeutics, Cambridge, MA.

Xue Shui, Associate Scientist I, Dicerna Pharmaceuticals, Cambridge, MA

Winny Wang, Senior Research Assistant, Brigham and Women's Hospital

Zhigang Wang, Ph.D. Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA

Sherry Xiao, MD MPH Ph.D., Research Scientist, PatientsLikeMe, Inc.

Li Xing, Ph.D.  Senior Director, Wuxi AppTec, Boston, MA

Chunxiao Yu, Ph.D. Postdoctoral Research Fellow, Harvard Medical School

Cindy Yang, MBA, Associate Director, Contracts and Alliance Management, Biogen Inc.

Jingzhong Jeff Zhang, Ph.D. Principal Scientist, Medica Corporation

Rui Zhang, MBA, Partner of ETP Venture

Wei Zhang, Ph.D. Staff Scientist, Siemens Healthcare Diagnostics, Norwood, MA

Youxin Zhang, Ph.D. Director, New Product Planning, BeiGene, Boston, MA

 

Board of Directors

Zhihong Chen, Ph.D. Past President (2011-2012)

Chaoyang Dai, Ph.D. Past president (2010-2011), President, Boston Biosolutions

Jun Han, Ph.D. Founding President, CEO, SOTA International LLC, Boston, MA

Shiwen Lin, Ph.D. Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA

Susan Qu, Ph.D. MBA,  Past president (2015-2016), External Manufacturing Integrated Risk Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA

Lixin Shen, Ph.D. President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China

Eric Shi, Ph.D. Investigator, GSK, Waltham, MA

Zhao-Kui (ZK) Wan, Ph.D. Past-President (2009-2010), Head of Chemistry and a member of the leadership team at Johnson & Johnson's Asian Pacific Discovery Center in Shanghai, China

Yihan Wang, Ph.D. President, Shenzhen TargetRx, Inc., Shenzhen, China

Erxi Wu, Ph.D. Director, Neuro-oncology Research Center, Baylor Scott & White Health; Associate Prof., Texas A&M University

Junjun Wu, Ph.D. Past President (2007-2009), CEO, WuXi AllNature Biotech LLC, Jiangsu, China

Xiang Yang Yu, Ph.D. Past president (2013-2014), Program Manager, Accellient Partners LLC, Waltham, MA

Zhiyong Yang, Ph.D. Past president (2014-2015), Associate Research Fellow, Pfizer, Cambridge, MA

 

CABA Advisors

Youssef Bennani, Ph.D. Site Head, Vertex Pharmaceuticals Inc.-Canada

Tim Clackson, Ph.D. President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Yuan-Hua Ding, Ph.D. Senior Director & Head of External R&D Innovation - Asia, Pfizer

Pierre Dodion, M.D., MBA, Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA

Chen Li, Ph.D. Chief Executive Officer, Hua Medicine, Inc., Shanghai, China

Luke Li, Ph.D. Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer

Shi Li, Ph.D. CEO, Zerun Biotechnology, Shanghai, China

Yuanli Liu, Ph.D. Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health

Dawei Ma, Ph.D. Professor, Shanghai Institute of Organic Chemistry, Shanghai, China

Tarek Mansour, Ph.D. EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada

Tse Ping, Chairman, Sino Biopharmaceutical Ltd., Beijing, China

John Piwinski, Ph.D. Principal, JJPiwinski Pharma Consulting, LLC, New York, NY

Steve Projan, Ph.D. Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD

Tomi Sawyer, Ph.D. Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA

Liming Shao, Ph.D. Professor, Fudan University, Shanghai, China

Suvit Thaisrivongs, Ph.D. Vice President, Pfizer, Inc., Cambridge. MA

Roger Tung, Ph.D. CEO and President, Concert Pharmaceuticals, Lexington, MA

Yibin Xiang, Ph.D. CSO, Sanhome Pharma

Sunny Xie, Ph.D. Professor, Northeastern University

Gangfeng Xu, Ph.D. Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories

Steve Yang, Ph.D. Executive VP & COO, Wuxi Apptec

Howard Yuwen, Ph.D. Co-founder & VP Corporate Development & Regulatory Affairs, Genesun Pharmaceuticals

Zhaohui Sunny Zhou, Ph.D. Associate Professor, Department of Chemistry and Chemical Biology and Faculty Fellow, Barnett Institute of Chemical and BiologicalAnalysis, Northeastern University

CABA Thank the dedicated service from the retired EC members: Sue Ma and Zhigang Wang